First Time Loading...

Immatics NV
NASDAQ:IMTX

Watchlist Manager
Immatics NV Logo
Immatics NV
NASDAQ:IMTX
Watchlist
Price: 10.81 USD 8.86%
Updated: May 2, 2024

Immatics NV
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immatics NV
Operating Income Peer Comparison

Comparables:
BNTX
MOR
CVAC
BIO
FYB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Immatics NV
NASDAQ:IMTX
Operating Income
-€101.7m
CAGR 3-Years
-13%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Operating Income
€908m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Income
-€232.9m
CAGR 3-Years
N/A
CAGR 5-Years
-42%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Operating Income
-€269.7m
CAGR 3-Years
-35%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Income
€120.3m
CAGR 3-Years
N/A
CAGR 5-Years
57%
CAGR 10-Years
8%
Formycon AG
XETRA:FYB
Operating Income
-€17.7m
CAGR 3-Years
-100%
CAGR 5-Years
-64%
CAGR 10-Years
N/A

See Also

What is Immatics NV's Operating Income?
Operating Income
-101.7m EUR

Based on the financial report for Dec 31, 2023, Immatics NV's Operating Income amounts to -101.7m EUR.

What is Immatics NV's Operating Income growth rate?
Operating Income CAGR 5Y
-24%

The average annual Operating Income growth rates for Immatics NV have been -13% over the past three years , -24% over the past five years .